机译:组织因子通路抑制剂 2:区分良恶性卵巢肿瘤的潜在诊断标志物
Department of Gynecology, Ms.Clinic MayOne;
Department of Obstetrics and Gynecology,Nara Medical University;
Bioscience Division, Research and Development Department,Tosoh Corporation;
CA125; combination assay; diagnostic marker; ovarian cancer; tissue factor pathway inhibitor 2;